Larimar Therapeutics (LRMR) Assets Growth (1y) (2014 - 2025)
Larimar Therapeutics (LRMR) Assets Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.16% |
| Sep 30, 2025 | -14.46% |
| Jun 30, 2025 | -36.76% |
| Mar 31, 2025 | -31.44% |
| Dec 31, 2024 | 108.71% |
| Sep 30, 2024 | 110.69% |
| Jun 30, 2024 | 112.29% |
| Mar 31, 2024 | 108.74% |
| Dec 31, 2023 | -24.11% |
| Sep 30, 2023 | -21.85% |
| Jun 30, 2023 | 77.74% |
| Mar 31, 2023 | 66.95% |
| Dec 31, 2022 | 60.68% |
| Sep 30, 2022 | 51.26% |
| Jun 30, 2022 | -22.34% |
| Mar 31, 2022 | -23.43% |
| Dec 31, 2021 | 1,533.79% |
| Sep 30, 2021 | 1,726.33% |
| Jun 30, 2021 | 1,580.81% |
| Mar 31, 2021 | 26.21% |